In the non-inflamed lung, surfactant protein A (SP-A) acts as an anti-inflammatory molecule through its effects on macrophage (M ) function, modulating cytokine and reactive oxygen and nitrogen intermediate production. The receptors responsible for these effects of SP-A on human M are not clear, although SP-A binding to several proteins has been described. In this study, we demonstrate high-affinity specific binding of SP-A to primary human M . SP-A binding was inhibited by EGTA, indicating calciumdependence. However, mannan did not inhibit SP-A binding, suggesting that binding is mediated by a direct protein-protein interaction that does not involve carbohydrate recognition. Our laboratory has previously shown that SP-A is rapidly endocytosed by human M into discrete vesicles. Although previous work indicates that SP-A is ultimately degraded by murine M over time, the trafficking pathway of SP-A through M following uptake has not been reported, and is of potential biologic importance. We examined trafficking of SP-A in human M by electron and confocal microscopy, and show for the first time that SP-A is endocytosed by primary human M through clathrincoated pits and co-localizes sequentially over time with the early endosome marker EEA1, late endosome marker lamp-1, and lysosome marker cathepsin D. We conclude that SP-A binds to receptor(s) on human M , is endocytosed by a receptor-mediated, clathrin-dependent process, and traffics through the endolysosomal pathway. These studies provide further insight into the interactions of SP-A with the M cell surface and intracellular compartments that play important roles in SP-A modulation of lung M biology.
Introduction
Alveolar M are the first line of cellular defense against inhaled environmental particles and infectious microorganisms that reach the lungs. These cells express a broad range of immune receptors, including Fc receptors, complement receptors, Toll-like receptors, and scavenger receptors (17) , as well as the macrophage mannose receptor (36) , DC-SIGN (34) , and dectin-1 (37) . These receptors contribute to the high phagocytic capacity of these cells, especially with regard to non-opsonic phagocytosis. Despite constant stimulation by inhaled particles and pathogens, alveolar M display an antiinflammatory phenotype which includes altered cytokine responses (8) and reduced oxidant production in response to stimuli (26) , a phenomenon which has been described elsewhere as "alternative activation" (11) . There has been considerable interest in the discovery of those factors that induce alternative activation states in M . Data are emerging which indicate components of pulmonary surfactant, especially surfactant proteins A and D, play important roles in host innate immunity, both as innate defense proteins and as modulators of cellular immune activities (6,41).
Pulmonary surfactant is a complex mixture of proteins and lipids best known for its role in reducing surface tension at the air-liquid interface in the lung. Resident alveolar M are bathed in surfactant and have been shown to ingest abundant amounts of this material (24) . Therefore, the role of surfactant components in the induction and/or maintenance of an anti-inflammatory alveolar M phenotype has been of great interest (41) . The most abundant surfactant-associated protein (by weight) is surfactant protein A (SP-A), a member of the collectin protein family, which also includes immune molecules such as mannose-binding protein and complement component C1q. In addition to its ability to specifically bind carbohydrates and lipid with high affinity in the presence of calcium, SP-A has been shown to have multiple effects on M biology in vitro, including 4 increased pattern recognition receptor activity, increased phagocytosis, altered production of pro-inflammatory cytokines, and decreased production of nitric oxide in response to stimuli (33, 42) . Recent work in our laboratory has shown that SP-A also inhibits production of reactive oxygen intermediates by decreasing the activity of the NADPH oxidase through a reduction in p47 phox association with the phagosome (7). These effects were observed both with pre-incubation of the cells with SP-A and when SP-A was added simultaneous with a phagocytic or chemical stimulus, indicating the importance of early interactions of SP-A with the M .
SP-A effects on M are believed to be mediated by interactions of this protein with its receptor(s) on the M surface (42) . Several receptor candidates have been identified, however, the role of these proteins in SP-A binding to primary human M remains unclear. Following binding, SP-A enters discrete vesicles in the macrophage cytoplasm (10) . These vesicles have not been characterized, nor has the nature of the endocytic pathway been explored. In this study, we characterized SP-A binding to primary human monocyte-derived M using fluorescently-labeled SP-A. We then examined the kinetics of SP-A uptake using a novel macrophage ELISA and determined the role of clathrin in SP-A endocytosis by electron microscopy using a biotin-avidin bridging technique to label M -bound SP-A with gold in situ. Finally, we characterized the trafficking of internalized SP-A in M using indirect immunofluorescence and confocal microscopy to co-localize SP-A with markers of the endolysosomal pathway. Our data provide evidence that SP-A binds with high affinity to human M in a calcium-dependent manner, is endocytosed by a receptor-mediated process through clathrin-coated pits, and traffics through the endolysosomal pathway in primary human M . Alexa-647 succinimidyl ester, biotin-xx succinimidyl ester, Alexa-488 chicken anti-rabbit IgG, Alexa-546 donkey anti-goat IgG, and Alexa-647 chicken anti-mouse IgG were purchased from Molecular Probes (Eugene, OR).
Materials and Methods

Proteins
Surfactant protein A purification: SP-A was purified as reported previously (7).
Briefly, human alveolar proteinosis bronchial lavage fluid was centrifuged at 20,000x g, washed repeatedly, and eluted using 2 mM EDTA at 4 o C. SP-A was purified from the supernatant by separation over a mannose-sepharose affinity chromatography column, and EDTA removed by dialysis against 10 mM HEPES + 25 mM NaCl. All steps were performed under sterile conditions at 4 o C whenever possible. Endotoxin-free water (Baxter, Round Lake, IL) was used for all steps to reduce LPS contamination. Purified protein was examined by SDS-PAGE and Western blot using rabbit anti-SP-A antiserum 6 and endotoxin contamination was determined using a Limulus Amoebocyte Lysate assay kit with E. coli LPS standards (Bio-Whittaker / Cambrex, East Rutherford, NJ).
Endotoxin concentration was 0.25 pg per µg protein.
SP-A labeling:
Purified SP-A was incubated with Alexa-647 succinimidyl ester or biotin-xx succinimidyl ester for 1 h at room temperature according to the manufacturer's instructions, and free label removed by extensive dialysis against 10 mM HEPES.
Labeled proteins were examined by SDS-PAGE under reducing and denaturing conditions and stained for total protein using colloidal Coomassie or transferred to nitrocellulose for Western blot using rabbit anti-SP-A antiserum. Endotoxin concentration was 0.25 pg per µg protein.
Liposome aggregation: Unilamellar vesicles were generated by probe tip sonication of lipid [DPPC:PE:PG (9:3:2)] at 1 mg/ml in buffer (5 mM Tris-HCl + 0.1 mM EDTA + 150 mM NaCl, pH 7.4) for 30 min on a setting of 5. SP-A-mediated aggregation of liposomes was measured by monitoring the change in absorbance at 400 nm using a plate spectrophotometer as described (16) . SP-A (20 µg/ml) or buffer control was added to the wells containing lipid (400 µg/ml), and the change in absorbance at 400 nm was monitored in the presence or absence of CaCl 2 (2.5 mM) for 25 min.
Cell preparation: Monocyte-derived macrophages (M ) were obtained as described previously (7) . Briefly, blood was obtained from healthy adult volunteers using an approved IRB protocol for human subjects at the Ohio State University. Human PBMC were isolated from heparinized peripheral blood using We next assessed the functional activity of the labeled and unlabeled SP-As using a standard assay for determining SP-A activity, i.e., measurement of its ability to aggregate surfactant-like liposomes in the presence of calcium (16) . As seen in figure 1C , unlabeled SP-A preparations significantly increased liposome A 400 in the presence of calcium, indicating that SP-A aggregated the liposomes. This effect was SP-A-and calciumdependent, as no significant increase in A 400 was seen in the absence of protein [ figure   1C ], and addition of EDTA to the reaction reversed SP-A's effects (data not shown).
Labeling of SP-A with biotin or Alexa-647 did not inhibit the ability of SP-A to aggregate lipid [ figure 1C ], indicating these proteins are functionally active. We used the two assays described above to calculate the affinity of SP-A binding to human M . Our results demonstrate that SP-A binding to human M is of high affinity that is specific, saturable, and dependent on divalent cations; the binding affinities obtained by non-linear regression in both assays were comparable, with a mean K d of 9.95 ± 3.68 nM (mean ± SEM, n = 6). was resistant to removal from M with EGTA prior to cell lysis (data not shown),
SP-
suggesting that cell-associated SP-A is rapidly internalized, consistent with receptormediated uptake.
Endocytosis of SP-A is clathrin-mediated. Endocytosis of receptor-bound ligands may
occur through several mechanisms, one of which is clathrin-coated vesicle assembly and internalization (14) . We examined endocytosis of SP-A using biotin-labeled SP-A conjugated to avidin-gold in situ. M were incubated with biotin-SP-A, unlabeled SP-A negative control, or biotin-LDL positive control for 5 min at 37 o C, fixed in gluteraldehyde, and then embedded, sectioned, stained, and examined using transmission electron microscopy. Gold labeling of cells incubated with unlabeled SP-A controls was low and non-specific [ figure 6A ]. As shown in figure 6B , in M incubated with biotin-SP-A, the vast majority of gold particles were localized to electron-dense coated pits and [ figure 7B ] and cathepsin D [ figure 7C ] was initially low (baseline), and then increased over time. Quantification of SP-A co-localization with each of these markers was determined for each time point by counting and is shown in figure 7D . Together, these data provide evidence that SP-A traffics through the endolysosomal pathway in human M , and that the SP-A-containing vesicles mature into lysosomes.
Discussion
Alveolar macrophages are believed to originate from two sources: local replication, and monocyte / macrophage migration. Limited data in vivo suggest that alveolar macrophage replication may occur in the absence of inflammatory stimuli, while significant proliferation of alveolar macrophages in vivo has been observed in several inflammatory models of lung disease (8) . Under normal, non-inflammatory conditions, however, the primary source of macrophages in the alveoli appears to be transmigration of blood monocytes and/or interstitial macrophages into the alveolar space, where they encounter lung-specific molecules capable of maturing them into prototypical "alternatively activated" M (11, 17) . In this report, we have used the human monocyte-derived 
